Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Mult Scler. 2019 Jul 31;26(11):1360–1371. doi: 10.1177/1352458519864928

Table 3.

Comparison of optical coherence tomography measures and letter-acuity scores between groups

AQP4-ON
vs.
MOG-ON
AQP4-ON
vs.
MS-ON
MOG-ON
vs.
MS-ON
AQP4-ON
vs.
HC
MOG-ON
vs.
HC
MS-ON
vs.
HC
Betad
(95% CI)
P Betad
(95% CI)
P Betad
(95% CI)
P Betad
(95% CI)
P Betad
(95% CI)
P Betad
(95% CI)
P
OCT measures, μm
 Global pRNFLa 6.0
(−0.5 to 12.5)
0.07 −11.5
(−16.8 to −6.3)
<0.001 −17.5
(−23.8 to −11.2)
<0.001 −24.1
(−29.3 to −18.8)
<0.001 −30.1
(−36.3 to −23.8)
<0.001 −12.5
(−17.5 to −18.8)
<0.001
  Superior quadranta 6.8
(−2.7 to 16.3)
0.16 −20.5
(−28.8 to −12.2)
<0.001 −27.3
(−36.8 to −17.7)
<0.001 −34.1
(−41.8 to −26.4)
<0.001 −40.9
(−49.9 to −31.9)
<0.001 −13.6
(−21.4 to −26.4)
0.001
  Nasal quadranta 2.4
(−1.7 to 6.6)
0.25 −5.6
(−9.3 to −1.9)
0.001 −8.0
(−12.2 to −3.9)
<0.001 −11.9
(−16.7 to −7.0)
<0.001 −14.3
(−19.5 to −9.1)
<0.001 −6.3
(−11.1 to −7.0)
0.01
  Inferior quadranta 5.4
(−5.9 to 16.8)
0.35 −21.9
(−31.2 to −12.6)
<0.001 −27.3
(−37.9 to −16.7)
<0.001 −39.5
(−49.0 to −30.0)
<0.001 −44.9
(−55.7 to −34.2)
<0.001 −17.6
(−26.1 to −30.0)
<0.001
  Temporal quadranta 9.1
(3.1 to 15.1)
0.003 1.8
(−2.8 to 6.4)
0.43 −7.2
(−13.2 to −1.3)
0.02 −11.2
(−15.9 to −6.5)
<0.001 −20.2
(−26.3 to −14.2)
<0.001 −13
(−17.7 to −6.5)
<0.001
 GCIPLb −1.6
(−5.5 to 2.3)
0.43 −9.1
(−13.1 to −5.1)
<0.001 −7.6
(−11.9 to −3.2)
0.001 −21.0
(−23.9 to −18)
<0.001 −19.4
(−22.8 to −16.0)
<0.001 −11.8
(−15.4 to −18.0)
<0.001
 INLb −0.5
(−2.7 to 1.6)
0.62 −0.6
(−2.5 to 1.2)
0.50 −0.1
(−2.4 to 2.2)
0.93 −1.1
(−2.5 to 0.3)
0.14 −0.5
(−2.5 to 1.5)
0.60 −0.4
(−2.2 to 0.3)
0.62
 ONLb −3.4
(−6.6 to −0.2)
0.04 −3.7
(−6.2 to −1.2)
0.004 1.1
(−3.0 to 5.2)
0.61 −3.2
(−5.9 to −0.6)
0.02 0.1
(−3.4 to 3.6)
0.95 0.5
(−2.4 to 3.4)
0.75
Letter-acuity scoresc
 100% contrast (HCLA) −22.3
(−30.0 to −14.7)
<0.001 −21.7
(−29.4 to −14.0)
<0.001 0.6
(−5.5 to 6.7)
0.85 −28.0
(−34.7 to −21.3)
<0.001 −5.7
(−10.4 to −1.0)
0.02 −6.3
(−11.1 to −1.4)
0.01
 2.5% contrast (LCLA) −3.1
(−8.7 to 2.5)
0.28 −14.7
(−19.4 to −9.9)
<0.001 −11.6
(−17.7 to −5.5)
<0.001 −23.0
(−27.0 to −19.1)
<0.001 −20.0
(−25.4 to −14.5)
<0.001 −8.4
(−13.0 to −3.7)
0.001
a

Available for 65 AQP4-ON, 27 MOG-ON, 47 MS-ON and 60 HC eyes

b

Available for 69 AQP4-ON, 27 MOG-ON, 47 MS-ON and 59 HC eyes

c

Available for 56 AQP4-ON, 21 MOG-ON, 47 MS-ON and 58 HC eyes

d

Results are derived from unadjusted linear generalized estimating equations (GEE) models. For OCT measures, the beta coefficients correspond to difference in μm between groups. For letter-acuity scores, the beta coefficients correspond to difference in number of letters correct between groups.

Abbreviations: ON: optic neuritis; AQP4-ON: aquaporin-4-IgG seropositive ON; MOG-ON: myelin oligodendrocyte glycoprotein-IgG seropositive ON; MS-ON: multiple sclerosis ON; HC: healthy control; CI: confidence interval; pRNFL: peri-papillary retinal nerve fiber layer; GCIPL: ganglion cell+inner plexiform layer; INL: inner nuclear layer; ONL: outer nuclear layer; HCLA: high-contrast letter-acuity; LCLA: low-contrast letter acuity